From Medscape Diabetes & Endocrinology

Coverage from the

American Thyroid Association (ATA) 89th Annual Meeting

October 30 - November 03, 2019; Chicago, IL

October 30 - November 03, 2019 Chicago, IL
  • ATA 2019 'Growing Concern': Incorrect Doses of Compounded Levothyroxine "Dramatic" variations in the amount of active ingredient were found in compounded liquid versions of levothyroxine (LT4) in a new study. The "surprise" results are a cause for concern, say researchers.
  • ATA 2019 New Imaging Device Reduces Hypocalcemia After Thyroidectomy The near-infrared light imaging device identifies parathyroid glands well before visualization with the naked eye, enabling surgeons to better avoid damaging them, with the potential to reduce hypocalcemia.
  • ATA 2019 AI Thyroid Nodule Classification Could Reduce Biopsies by 50% A new deep learning AI system uses image similarity to generate unique fingerprints of thyroid nodules, with the potential to reduce unnecessary biopsies compared with other noninvasive classification.

Conference News

Popular News from ATA 2018

Medscape Diabetes© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage